Cargando…
Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases
Case series Patient: Male, 87 • Male, 63 Final Diagnosis: Recurrent respiratory papillomatosis Symptoms: Cough • dyspnea Medication: — Clinical Procedure: — Specialty: Pulnonology OBJECTIVE: Unusual clinical course BACKGROUND: Recurrent respiratory papillomatosis (RRP), caused by human papillomaviru...
Autores principales: | Bedoya, Armando, Glisinski, Kristen, Clarke, Jeffrey, Lind, Richard N., Buckley, Charles Edward, Shofer, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551929/ https://www.ncbi.nlm.nih.gov/pubmed/28757601 http://dx.doi.org/10.12659/AJCR.904416 |
Ejemplares similares
-
Systemic Bevacizumab for Severe Recurrent Respiratory Papillomatosis
por: Tatineni, Swetha, et al.
Publicado: (2022) -
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
por: MOHR, MICHAEL, et al.
Publicado: (2014) -
Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single‐center experience of eight patients
por: Liu, Zengjun, et al.
Publicado: (2023) -
Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review
por: Pogoda, Louis, et al.
Publicado: (2022) -
Systemic and Intralesional Bevacizumab in Juvenile Onset Recurrent Respiratory Papillomatosis: A Report of Two Cases
por: Goyal, Arun, et al.
Publicado: (2021)